Cargando…

The potential of the gut microbiome for identifying Alzheimer’s disease diagnostic biomarkers and future therapies

Being isolated from the peripheral system by the blood–brain barrier, the brain has long been considered a completely impervious tissue. However, recent findings show that the gut microbiome (GM) influences gastrointestinal and brain disorders such as Alzheimer’s disease (AD). Despite several hypoth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhan, Yu, Al-Nusaif, Murad, Ding, Cong, Zhao, Li, Dong, Chunbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174259/ https://www.ncbi.nlm.nih.gov/pubmed/37179559 http://dx.doi.org/10.3389/fnins.2023.1130730

Ejemplares similares

Bone Marrow Stromal Cell Antigen 2: Is a Potential Neuroinflammation Biomarker of SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis in Pre-symptomatic Stage
por: Xu, Xiaojiao, et al.
Publicado: (2022)

Machine learning models identify ferroptosis-related genes as potential diagnostic biomarkers for Alzheimer’s disease
por: Deng, Yanyao, et al.
Publicado: (2022)

Multiple Dural Arteriovenous Fistulas as the Mystery of Rapidly Progressive Dementia with Bilateral Thalamic Lesions
por: Zhan, Yu, et al.
Publicado: (2022)

Role of Glia-Derived Extracellular Vesicles in Neurodegenerative Diseases
por: Li, Tianbai, et al.
Publicado: (2021)

Unlocking the Potential of the Human Microbiome for Identifying Disease Diagnostic Biomarkers
por: Hajjo, Rima, et al.
Publicado: (2022)

MicroRNAs in Alzheimer’s Disease: Function and Potential Applications as Diagnostic Biomarkers
por: Wei, Wei, et al.
Publicado: (2020)

Editorial: Biomarkers of Alzheimer’s Disease: The Present and the Future
por: Lehmann, Sylvain, et al.
Publicado: (2016)

Pro-Apoptotic Kinase Levels in Cerebrospinal Fluid as Potential Future Biomarkers in Alzheimer’s Disease
por: Paquet, Claire, et al.
Publicado: (2015)

A Bibliometric Review on Gut Microbiome and Alzheimer’s Disease Between 2012 and 2021
por: Trejo-Castro, Alejandro I., et al.
Publicado: (2022)

Abnormal Vacuole Membrane Protein-1 Expression in Parkinson’s Disease Patients
por: Al-Nusaif, Murad, et al.
Publicado: (2022)

Decoding the role of gut microbiota in Alzheimer’s pathogenesis and envisioning future therapeutic avenues
por: Liang, Junyi, et al.
Publicado: (2023)

The Gastrointestinal Tract Microbiome and Potential Link to Alzheimer’s Disease
por: Hill, James M., et al.
Publicado: (2014)

Gut Microbiome Signatures Are Biomarkers for Cognitive Impairment in Patients With Ischemic Stroke
por: Ling, Yi, et al.
Publicado: (2020)

Alzheimer's disease and the microbiome
por: Bhattacharjee, Surjyadipta, et al.
Publicado: (2013)

Network-Based Biomarkers in Alzheimer’s Disease: Review and Future Directions
por: Gomez-Ramirez, Jaime, et al.
Publicado: (2014)

Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer’s Disease
por: Zhu, Feiqi, et al.
Publicado: (2020)

Gut microbiome: A potential indicator for predicting treatment outcomes in major depressive disorder
por: Dong, Zaiquan, et al.
Publicado: (2022)

Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer’s disease
por: Noor Eddin, Ahmed, et al.
Publicado: (2023)

Identifying Changepoints in Biomarkers During the Preclinical Phase of Alzheimer’s Disease
por: Younes, Laurent, et al.
Publicado: (2019)

The Biomarkers for Identifying Preclinical Alzheimer's Disease via Structural and Functional Magnetic Resonance Imaging
por: Zhou, Yanhong, et al.
Publicado: (2016)

Perivascular spaces as a potential biomarker of Alzheimer’s disease
por: Lynch, Miranda, et al.
Publicado: (2022)

Periodontitis, Microbiomes and their Role in Alzheimer’s Disease
por: Pritchard, Anna B., et al.
Publicado: (2017)

The Gut Microbiome and Substance Use Disorder
por: Russell, Jordan T., et al.
Publicado: (2021)

Oral Mucosa Derived α−Synuclein as a Potential Diagnostic Biomarker for Parkinson′s Disease
por: Zheng, Yuanchu, et al.
Publicado: (2022)

Diagnostic Potential of Pulsed Arterial Spin Labeling in Alzheimer's Disease
por: Trebeschi, Stefano, et al.
Publicado: (2016)

Potential Diagnostic Applications of Multi-Delay Arterial Spin Labeling in Early Alzheimer’s Disease: The Chinese Imaging, Biomarkers, and Lifestyle Study
por: Sun, Mengfan, et al.
Publicado: (2022)

Cofilin 2 in Serum as a Novel Biomarker for Alzheimer’s Disease in Han Chinese
por: Sun, Yingni, et al.
Publicado: (2019)

Tryptophan Metabolism by Gut Microbiome and Gut-Brain-Axis: An in silico Analysis
por: Kaur, Harrisham, et al.
Publicado: (2019)

In vivo Brainstem Imaging in Alzheimer’s Disease: Potential for Biomarker Development
por: Braun, David J., et al.
Publicado: (2018)

Potential biomarkers of Alzheimer’s disease and cerebral small vessel disease
por: Zou, Chun, et al.
Publicado: (2022)

Pathogenic microbes, the microbiome, and Alzheimer’s disease (AD)
por: Hill, James M., et al.
Publicado: (2014)

Gut microbiome alterations in preclinical Alzheimer’s disease
por: Jung, Joon Hyung, et al.
Publicado: (2022)

Identification of diagnostic biomarkers in Alzheimer’s disease by integrated bioinformatic analysis and machine learning strategies
por: Jin, Boru, et al.
Publicado: (2023)

MicroRNAs in Huntington’s Disease: Diagnostic Biomarkers or Therapeutic Agents?
por: Dong, Xiaoyu, et al.
Publicado: (2021)

Aberrantly hypermethylated ARID1B is a novel biomarker and potential therapeutic target of colon adenocarcinoma
por: Baldi, Salem, et al.
Publicado: (2022)

Gut microbiome alterations in Alzheimer’s disease
por: Vogt, Nicholas M., et al.
Publicado: (2017)

Transmembrane Amyloid-Related Proteins in CSF as Potential Biomarkers for Alzheimer’s Disease
por: Lopez-Font, Inmaculada, et al.
Publicado: (2015)

REPS1 as a Potential Biomarker in Alzheimer’s Disease and Vascular Dementia
por: Luo, Jiefeng, et al.
Publicado: (2022)

Diagnostic and prognostic potential of the oral and gut microbiome for lung adenocarcinoma
por: Lim, Mi Young, et al.
Publicado: (2021)

Biomarkers in Alzheimer’s Disease
por: Riverol, Mario, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_p67ar1i9cnth2m51jdn8mtqh6u